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Abstract
In rheumatoid arthritis, a significant proportion of cytokine and chemokine synthesis is attributed to innate immune
mechanisms. TLR4 is a prominent innate receptor since several endogenous ligands known to activate the innate immune
system bind to it and may thereby promote joint inflammation. We generated TLR4 deficient DBA1J mice by backcrossing
the TLR4 mutation present in C3H/HeJ strain onto the DBA1J strain and investigated the course of collagen-induced arthritis
in TLR4 deficient mice in comparison to wild type littermates. The incidence of collagen- induced arthritis was significantly
lower in TLR4 deficient compared to wild type mice (59 percent vs. 100 percent). The severity of arthritis was reduced in the
TLR4 deficient mice compared to wild type littermates (mean maximum score 2,54 vs. 6,25). Mice deficient for TLR4 were
virtually protected from cartilage destruction, and infiltration of inflammatory cells was reduced compared to wt mice. In
parallel to the decreased clinical severity, lower anti-CCP antibody concentrations and lower IL-17 concentrations were
found in the TLR4 deficient mice. The study further supports the role of TLR4 in the propagation of joint inflammation and
destruction. Moreover, since deficiency in TLR4 led to decreased IL-17 and anti-CCP antibody production, the results
indicate a link between TLR4 stimulation and the adaptive autoimmune response. This mechanism might be relevant in
human rheumatoid arthritis, possibly in response to activating endogenous ligands in the affected joints.
Citation: Pierer M, Wagner U, Rossol M, Ibrahim S (2011) Toll-Like Receptor 4 Is Involved in Inflammatory and Joint Destructive Pathways in Collagen-Induced
Arthritis in DBA1J Mice. PLoS ONE 6(8): e23539. doi:10.1371/journal.pone.0023539
Editor: Carol Feghali-Bostwick, University of Pittsburgh, United States of America
Received April 27, 2011; Accepted July 19, 2011; Published August 17, 2011
Copyright:  2011 Pierer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by the Deutsche Forschungsgemeinschaft, grant number Pi 624/1-2 and IB 24/5-1. The funder had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: matthias.pierer@medizin.uni-leipzig.de
Introduction
Rheumatoid arthritis is an autoimmune disease of diarthrodial
joints with unknown etiology. T cells, B-cells and cytokines such as
TNF alpha or IL-6 can be targeted therapeutically and are
therefore important pathogenic components in the process of
inflammatory mediated cartilage and bone destruction [1]. The
primary factors responsible for an adaptive immune response
targeting joints are not fully understood.
Toll-like receptors (TLR’s), promote innate and adaptive
immune responses, including induction of pro-inflammatory
cytokines and matrix metalloproteinases [2].
Based on animal data, innate immune activation is indispens-
able for induction and chronicity of arthritis. As such, the skg
arthritis or the IL-1ra 2/2 arthritis model are critical dependent
on innate immune system stimulation. However, the clear nature
of the ligands and the receptors for innate activation seem to
widely differ between models. In skg mice, the development of
arthritis is Dectin- dependent [3], while in the IL-1ra 2/2 model,
disease is critically dependent on TLR-function, namely TLR4
[4][5]. More evidence for a significant role of innate immune
activation stems from streptococcal cell wall-induced arthritis,
since MyD88 knockout mice are protected from joint inflamma-
tion in this model [6].
TLR’s are highly expressed in synovial tissue from individuals
with rheumatoid arthritis [7] and activation of synovial fibroblasts
by TLR ligands may induce chemotactic attraction of immune
cells [8]. Furthermore, an inhibitor of TLR4 has reduced
symptoms in patients with moderate to severe rheumatoid arthritis
in a preliminary phase 1 trial [9].
Beside TLR2, most endogenous ligands have been identified for
TLR4, among them sHSP alphaA crystallin, HSPB8 [10] or
Tenascin C [11]. Overall, the presence of these endogenous
ligands in the synovial membrane supports a significant role for
TLR4 in the pathogenesis of RA.
In collagen-induced arthritis, one of the most relevant animal
models of RA, no data using genetically TLR4 deficient animals
have been published yet. We therefore generated TLR4 deficient
DBA1J mice and compared CIA development with wild type
littermates.
Materials and Methods
Mice
Homozygous C3H/HeJ mice which carry a point mutation
within the coding region of the Tlr4 gene resulting in a non-
conservative substitution of a highly conserved proline by histidine
at codon 712 [12] were backcrossed at least 8 times to DBA/1J
mice (H-2
q) to bring the TLR4
2/2 mice to an arthritis-susceptible
H-2
q background. The mice were intercrossed, and homozygous
TLR4
2/2 DBA/1 mice were obtained. Mice were bred and
maintained at the animal facilities at the Medizinisch Experi-
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animal facility at the University of Rostock, Germany. The
animals were fed rodent chow and water ad libitum.
Ethics Statement. The local ethics committee (Regierungs-
pra ¨sidium Leipzig, TVV31/05) approved all experiments.
Genotyping
The C3H/HeJ TLR4 genotype was determined by PCR
amplification and restriction length polymorphism analysis perfor-
med on isolated tail DNA. The TLR4 genotype was detected using
the following primer pair (59-CACgACgTTgTAAAACgACT-
gATgCATTTgTgATCTACTCg-39) and (59-ggCAgCAATggC-
TACATCA-39) The gene amplification was performed in 25 mlo f
2.5 mM MgCl2, 0.4 mM dNTP, 1 mM of each primer, and 1 U of
AmpliTaq Gold DNA polymerase (Roche Applied Science,
Mannheim, Germany) in PCR buffer for 33 cycles (94uC for
30 s; 56uC for 30 s; 72uC for 30 s). Genotype was identified by
agarose gel electrophoresis after digestion with restriction enzyme
PagI (Fermentas, St.Leon-Rot GERMANY) for 4 hours at 37u
Celsius.
Induction of CIA and assessment of arthritis
Mice were immunized with 50 ml of a 1:1 (v/v) emulsion 0.1 M
acetic acid containing 50 mg of chick type II collagen (CII;
Chondrex) and 25 ml of incomplete Freund’s adjuvant (DBA/1J
(Chondrex, Redmond, WA, USA) at the base of the tail.
Development of arthritis was assessed three times weekly by two
blinded observers. The clinical severity of arthritis in each paw was
quantified according to a graded scale from 0 to 4, as follows: 0, no
swelling; 1, swelling in one digit or mild dorsal edema; 2, moderate
swelling affecting several digits; 3, severe swelling affecting most
digits; and 4, the most severe swelling and/or ankylosis. A total
arthritis score per mouse was determined by summarizing the
scores of all four extremities. The mean 6 SEM values were
determined. Incidence was defined as the cumulative percentage
of arthritic mice out of the total number of immunized mice
during the experiment.
T cell proliferation assays and cytokine production
Spleens were removed under aseptic conditions and single-cell
suspensions of mononuclear cells were prepared. The cells were
washed three times in culture medium before being suspended to
2610
6 mononuclear cells per milliliter in round-bottom 96-well
polystyrene microtiter plates (Nunc) in a total volume of 200 ml.
The culture medium consisted of RPMI 1640 with Glutamax II
(Invitrogen) supplemented with 50 IU/ml penicillin, 60 mg/ml
streptomycin, and 5% inactivated FBS (all from Invitrogen). For
lymphocyte stimulation, denatured pepsin-free T cell proliferation
grade CII (Chondrex) was added to cultures at final concentration
of 10 and 100 mg/ml. Cells were incubated at 37uC in humidified
air with 5% CO2. After 3 days cells were pulsed with 10 mlo f
3H
methylthymidine (1 mCi/well; Amersham Pharmacia Biotech) and
cultured for an additional 24 h. Cells were harvested onto glass-
fiber filters (PerkinElmer) and [
3H] thymidine incorporation was
measured in a liquid beta scintillation counter. The results were
expressed as cpm. For proliferation assays, cultures were done in
triplicates. FACS analysis of T cell populations was conducted by
surface staining for CD4 and CD25 (BD Biosciences) and for
intracellular Foxp3 (eBioscience) according to published protocols.
Culture fluid cytokine concentration of IL-17 was analyzed by
cytometric bead array (CBA; BD Biosciences) according to the
manufacturer’s protocol.
Measurement of collagen-specific Abs, anti CCP
antibodies and cytokines
Sera were collected at day 34 by retro orbital blood drawing
and at the day of sacrifice (day 91) from cardiac puncture blood
drawings. After the samples had fully coagulated, they were
centrifuged and the sera were stored at 280uC. Levels of CII-
specific IgG2a and IgG1 were determined by ELISA using CII-
coated (Chondrex) ELISA 96-well plates (Dynex Technologies) for
capture and goat anti-mouse IgG2a and IgG1 Abs (Caltag) for
detection. Absorbance (450 nm) was measured with an ELISA
plate reader (Wallac). The measurements were done in triplicate.
For each plate a standard consisting of pooled sera from arthritic
mice was applied and used to determine relative antibody
reactivity units.
Anti-CCP antibody titers were determined using the DIASTAT
Anti-CCP2 kit (second generation peptides; Axis-Shield Diagnos-
tics Ltd.) following manufacturer’s instructions with the following
modifications: for most experiments mouse sera were diluted 1:10
or 1:100 in sample diluent, and the secondary antibody was
substituted with alkaline phosphatase-conjugated goat anti-mouse
IgG (CALTAG Laboratories) diluted 1:1000 in PBS. The kit
standard was utilized without modification of the secondary
antibody to maintain consistency between plates.
Cytokine concentrations for IL-6, IL-12p70, IL-12/23/p40,
TNF-alpha, IL-10 and IL-17 were analyzed by cytometric bead
array (CBA; BD Biosciences) according to the manufacturer’s
protocol.
Histopathologic assessment
Mouse paws were fixed in 4% neutral buffered formalin (Sigma-
Aldrich) and then decalcified, cut, and stained with H&E or with
Nuclear Fast Rubine-Aniline Blue-Orange G. Four coronal
sections 80 um apart were scored by two independent observers,
at low power for cellular infiltration, exudation, and pannus, and
at low (610) and high (6100) power for bone erosion and cartilage
destruction. A semi quantitative graded scale from 0 to 3 was used,
as follows: 0, no changes; 1, mild changes; 2, moderate changes;
and 3, most severe changes observed in the experiments. Cartilage
destruction was determined as loss of cartilage in relation to the
total cartilage area. A mean score for each animal was determined
for each parameter, and the scores were averaged to determine
group means.
Statistics
We used Prism 5.0 to calculate means, SEM and statistical tests.
Differences between groups were calculated using two-tailed t test
for antibody responses, T cell proliferation measures and cytokine
concentrations. The Mann-Whitney U test was used for
differences between histological scores. Differences in arthritis
incidence were analyzed using Fishers exact test. P values less than
0.05 were considered significant.
Results
CIA is alleviated in TLR4 deficient mice
To investigate the role of TLR4 in murine collagen-induced
arthritis, TLR4 deficient C3H/HeJ mice were backcrossed for at
least 7–10 generations onto the CIA susceptible DBA/1J
background. DBA1/J-C3H/HeJ/C3H/HeJ mice proved to be
lps hypo-responsive since splenocytes did not produce TNF alpha
in response to lps while splenocytes derived from TLR4 wt/wt
littermates produced normal amounts (data not shown).
For collagen-induced arthritis in this strain, a protocol with
incomplete Freund’s adjuvant without heat-killed mycobacteria
TLR4 in Collagen-Induced Arthritis
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mice by mycobacterial substances [13]. DBA1/J mice deficient for
TLR4 and littermates carrying the wild type TLR4 alleles were
immunized with collagen II and were followed over a time period
of 90 days. As shown in Figure 1A, in the absence of functional
TLR4 the clinical severity of arthritis was lowered. Overt arthritis
developed at about the same time but showed a significantly
reduced incidence reaching only 67 percent over the observation
time compared to a 100 percent incidence in the wt groups.
Arthritis severity, as defined by the scoring method described in
the M&M section, was significantly milder in TLR4 defective mice
with a mean maximal score of 2,54 compared to 6,25 for the wt
groups (Figure 1B). This suppressive effect of TLR4 deficiency
became obvious approximately 2 weeks after arthritis onset and
was sustained in the chronic phase up to the end of the
observational period of 90 days.
TLR4 deficient mice are protected against joint
destruction
The clinically observed amelioration of arthritis was reflected by
suppression of joint destruction in the histological assessment of
H&E stained paw sections (Figure 2). Staining with Nuclear Fast
Rubine-Aniline Blue-Orange G shows significantly less bone
erosion and infiltration of pannus tissue in TLR4 deficient mice.
Mice deficient for TLR4 were virtually protected from cartilage
destruction in IFA induced CIA and infiltration by inflammatory
cells was significantly reduced in TLR4 defective mice compared
to wt mice. The overall inhibition of synovitis in TLR4 deficient
animals is shown in Figure 2E.
Figure 1. Incidence and severity of arthritis. Suppressed incidence
(A) and severity (B) of collagen induced arthritis (incomplete Freund’s
adjuvant) in TLR4 defective DBA/1J (n=17) compared to TLR4 pos/pos
(n=17) DBA1/J mice.
doi:10.1371/journal.pone.0023539.g001
Figure 2. Histological joint destruction in paw sections. Synovial
inflammation is suppressed in CIA in DBA1J TLR4 negative mice (A, C)
compared to wt mice (B, D). Representative front paw sections showing
wrist and carpal joints and stained in H&E, original magnification610 are
shown in (A) and (B) and interphalangeal joints with extensive pannus
formation andbone destruction stained with NuclearFast Rubine-Aniline
Blue-Orange G in (C) and (D), original magnification 6100. Histological
joint scores reflecting significantly suppressed inflammation and
cartilage and bone destruction in TLR4 defective mice are shown in (E).
doi:10.1371/journal.pone.0023539.g002
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The humoral response against collagen II is crucial in the
development of erosive arthritis. Despite the observed clinical
differences, however, the anti-collagen type II antibody concen-
trations of the Th1 dependent IgG2a subclass determined in the
peripheral blood at days 34 and 89 did not differ between TLR4
negative and positive mice (Figure 3A). For anti-collagen type II
IgG1 subclass antibodies, again no differences were measured
(data not shown).
The second pathogenetically relevant humoral response in
murine collagen induced arthritis is targeted against citrullinated
side chains of endogenous proteins [14]. In accordance with the
clinical picture of an attenuated joint destruction in TLR4
deficient mice, anti-citrullinated peptide antibody (ACPA) con-
centrations (anti-LXP) were significantly lower in the knockout
mice compared to wild type littermates at day 34 after
immunization, while anti-non-citrullinated control peptide anti-
body concentrations were comparable (Figure 3B).
T cell response and cytokine production in TLR4 deficient
arthritic mice
The response of CD4 positive T cells against peptide antigens
derived from the injected type II collagen is central for the
development of murine arthritis. When this response was tested ex
vivo by measurement of 3H thymidine incorporation following re-
stimulation with collagen II, a higher rate of proliferation was
unexpectedly detected in the TLR4 deficient group (Figure 3C),
which was reflected also by higher Interferon gamma concentra-
tions in vitro (data not shown). In view of the attenuated severity of
arthritis in those mice, increased proliferation of suppressive or
regulatory T cells was a possible explanation for this result. When
those cells were quantified, however, no difference between TLR4
deficient mice and wild type littermates in circulating Treg
numbers (as defined by CD25 positivity and intracellular Foxp3
expression) was seen (Figure 3D).
In an attempt to characterize the involved immune pathways,
serum concentrations of a panel of cytokines were determined.
Again somewhat unexpectedly, concentrations of the pro-
inflammatory cytokines IL-12p70, TNF alpha, MCP-1 and of
the regulatory cytokine IL-10 were higher in TLR4 negative mice
at day 34 after immunization (Figure 4 A). However, at day 90
after immunization, in the chronic stage of arthritis, the pro-
inflammatory cytokines IL-12p70, TNF alpha and MCP-1 were
suppressed in TLR4 deficient mice compared to wt mice (Figure 4
B).
In contrast, Il-17 concentrations, measured in vitro in spleen cell
cultures stimulated with either type II collagen or anti-CD3
antibodies, were higher in cultures derived from TLR4 positive
mice (Figure 4 C), suggesting that increased numbers of
differentiated Th17 cells were present in those ex vivo analyses,
and presumably also in vivo.
Figure 3. B and T cell responses. No significant difference in peripheral blood anti-collagen type II antibody concentrations of the IgG2a subclass
at days 34 and 89 in TLR4 negative versus positive groups of mice (A). Anti-cyclic citrullinted peptide (CCP) antibody concentrations (anti-LXP) are
significantly higher in TLR4 positive groups of mice at day 34 after immunization, while anti-non-citrullinated controle peptide antibody
concentrations are comparable (B). T cell recall responses in TLR4 negative mice were significantly stronger than in wt mice at the lower tested
antigen concentration (C). No influence on foxp3 positive Treg numbers was seen (D).
doi:10.1371/journal.pone.0023539.g003
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Recent evidence supports the pathogenic role of innate
stimulation via Toll-like receptors in animal models of arthritis
like SCW Arthritis, collagen type II antibody induced arthritis or
KB/N serum transfer arthritis. For one of the most relevant
models of rheumatoid arthritis, the collagen induced arthritis
(CIA) model, no data using genetically deficient animals have been
published.
Here we show that TLR4 deficient DBA mice develop collagen
induced arthritis with lower incidence and decreased severity,
thereby supporting a role for TLR4 in autoimmune arthritis.
In parallel to the reduced clinical severity in TLR4 deficient
mice, their anti-CCP antibody concentrations are lower. In
humans, it has recently been shown, that an increased frequency
of Th17 cells is associated with anti-CCP positive disease [15].
Consequently, the decreased IL-17 production of TLR4 deficient
splenocytes upon re-challenge with collagen II could be associated
with the observed decrease in anti-CCP antibodies, thereby
indicating a possible involvement of TLR4 in these responses. In
line with this result, the control of B cell responses has been shown
to depend on TLR stimulation [2], however, others have shown
that TLR derived signals are dispensable [16]. The chemical
nature of the antigens has been shown to contribute to this
discrepancy [17] and such differences might play a role for the
observed different effect of TLR4 deficiency for the generation of
anti- citrullinated peptide antibodies in contrast to identical
generation of anti- collagen antibodies.
In contrast to the reduced clinical severity of arthritis, however,
a more vigorous immune response to immunization with collagen
II seems to occur in TLR4 deficient mice, since both the serum
concentrations of the proinflammatory cytokines IL-12p70, TNF
alpha and MCP-1 (day 34) and the T cell responses against
collagen II are higher in this group. The augmented T cell
response despite the attenuated reduced clinical severity cannot be
attributed to Treg activation, since no numerical expansion of
suppressive Tregs was observed.
An alternative hypothesis is that the immune response against
collagen II is dissociated from the progression of joint disease,
while a Th17 dependent response against citrullinated peptide is a
driving force of destruction. This would also imply, that TLR4
deficiency is attenuating this anti-citrulline response, and therefore
suggest an involvement of TLR4 signalling in this response.
Endogenous ligands might play a relevant role in this process. In
line with this, direct TLR4 stimulation in CD4 T lymphocytes has
been shown to promote T helper 17 responses and to aggravate
the evolution of autoimmune diseases [18], indicating that the
observed decrease in IL-17 production may indeed contribute to
the suppressed arthritis in TLR4 defective mice. Results showing
that TLR4 together with Dectin-1 is necessary for he induction of
Th17 cells by mycobacteria have suggested a similar mechanism
[19]. However, reduced anti-CCP antibody response might be a
consequence of otherwise suppressed arthritis in TLR4 deficient
mice.
Taken together, the results thus suggest that after immunization
with collagen II, with the exception of ACPA generation and IL-
17 production, most early immune activation events occur in a
TLR4- independent manner, including anti- collagen antibody
formation and production of pro-inflammatory mediators. How-
ever, the strong immune reaction in TLR4 deficient mice does not
induce joint inflammation of the same magnitude as in TLR4 wt
mice. This data further support a role for endogenous ligands for
Figure 4. Cytokines in sera and in vitro splenocyte cultures. Serum cytokine concentrations measured at days 34 (A) and 91 (B) in TLR4
negative and TLR4 positive groups of mice. Significantly higher IL-12p70, TNF alpha, MCP-1 and IL-10 concentrations in TLR4 negative groups of mice
at day 34 after immunization, while at day 91 IL-12p40, TNF alpha and MCP-1 were higher in TLR4 positive mice. (C) Interleukin17 concentrations are
reduced in TLR4 deficient in vitro spleen cell cultures after 48 hours in the presence of type II collagen (100 ug/ml) or anti-CD3 antibodies (1 ug/
ml)(*p,0,05).
doi:10.1371/journal.pone.0023539.g004
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production.
The findings are in line with results of TLR4 inhibition with a
naturally occurring antagonist in the collagen induced arthritis
model and the IL-1ra 2/2 model [4], the KRN serum transfer
arthritis [20] as well as with results from the antigen-induced
arthritis model [11], for which tenascin was identified as critical
endogenous ligand of TLR4.
The results further strengthen the role of TLR4 in the
propagation of intra-articular inflammation and joint destruction.
Decreased IL-17 and ACPA production due to missing innate
response to endogenous TLR4 ligands may be reason for the
reduced severity of CIA in TLR4 deficient mice.
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